Cargando…

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers

Knowledge of the genetic landscape of aggressive well differentiated thyroid cancers (WDTC) is lacking. Retrospective review of institutional database was performed to identify locally-invasive thyroid carcinomas and a comparison cohort of low-risk WDTC. ThyroSeq v2 next-generation sequencing was pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mady, Leila J., Grimes, Michael C., Khan, Nayel I., Rao, R. Harsha, Chiosea, Simion I., Yip, Linwah, Ferris, Robert L., Nikiforov, Yuri E., Carty, Sally E., Duvvuri, Umamaheswar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229018/ https://www.ncbi.nlm.nih.gov/pubmed/32415114 http://dx.doi.org/10.1038/s41598-020-64635-8

Ejemplares similares

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2015)

Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology
por: Skaugen, John M., et al.
Publicado: (2022)

OR32-06 Disease-related Outcomes In Patients With Thyroid Cancer On Long Term Follow-up: Analysis Of 1487 Patients
por: Doerfler, William R, et al.
Publicado: (2023)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study
por: Yip, Linwah, et al.
Publicado: (2021)

TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation
por: Dixit, Ronak, et al.
Publicado: (2015)

Cost Impact of Molecular Testing for Indeterminate Thyroid Nodule Fine-Needle Aspiration Biopsies
por: Yip, Linwah, et al.
Publicado: (2012)

MON-LB79 Do Ultrasound Patterns and Clinical Parameters Modify the Probability of Thyroid Cancer Predicted by Molecular Testing in Thyroid Nodules With Indeterminate Cytology?
por: Figge, James J, et al.
Publicado: (2020)

OR21-02 Impact of Nodule Size on the Probability of Hurthle Cell Carcinoma and Other Cancers in Thyroid Nodules with Multiple Chromosomal Copy Number Alterations
por: Nikiforova, Marina N, et al.
Publicado: (2020)

Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management
por: Chiosea, Simion, et al.
Publicado: (2023)

Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
por: Folaron, Margaret, et al.
Publicado: (2019)

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study
por: Steward, David L., et al.
Publicado: (2018)

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
por: Borson, Steven, et al.
Publicado: (2022)

MON-LB84 Validation of TI-RADS (Thyroid Imaging, Reporting and Data System) Follow-Up Recommendations
por: Ravindra, Sindhura, et al.
Publicado: (2020)

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
por: Thomas, Joel, et al.
Publicado: (2020)

HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma
por: Meister, Kara S., et al.
Publicado: (2019)

Surgeon satisfaction and outcomes of tele-proctoring for robotic gynecologic surgery
por: Artsen, Amanda M., et al.
Publicado: (2021)

Assessing the learning curve associated with a novel flexible robot in the pre-clinical and clinical setting
por: Zhu, Toby S., et al.
Publicado: (2021)

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
por: Hedberg, Matthew L., et al.
Publicado: (2019)

Intraoperative identification of the human communicating nerve during thyroidectomy
por: Hodnett, Benjamin L., et al.
Publicado: (2015)

EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
por: Pinilla-Macua, Itziar, et al.
Publicado: (2017)

A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients
por: Taylor, Janielle K.‐A., et al.
Publicado: (2022)

Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract
por: Agaimy, Abbas, et al.
Publicado: (2021)

Transoral surgery for oropharyngeal tumors using the Medrobotics(®) Flex(®) System – a case report
por: Mandapathil, Magis, et al.
Publicado: (2015)

Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas
por: Warda, Firas, et al.
Publicado: (2022)

In vitro FRAP reveals the ATP-dependent nuclear mobilization of the exon junction complex protein SRm160
por: Wagner, Stefan, et al.
Publicado: (2004)

SAT568 A Case Of Medullary Thyroid Cancer Associated With Cutaneous Metastasis: A Rare And Aggressive Presentation
por: Vaghasia, Nishit, et al.
Publicado: (2023)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Synchronous Independent Papillary Thyroid Carcinomas in Struma Ovarii and the Thyroid Gland With Different RAS Mutations
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2018)

Sex Differences in the Regulation of Offensive Aggression and Dominance by Arginine-Vasopressin
por: Terranova, Joseph I., et al.
Publicado: (2017)

Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2022)

ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer
por: Bill, Anke, et al.
Publicado: (2015)

Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2019)

PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma
por: Chiosea, Simion I, et al.
Publicado: (2013)

Clinicopathologic Characteristics of Thyroid Nodules Positive for PTEN Mutations on Preoperative Molecular Testing
por: Quaytman, Jacob, et al.
Publicado: (2021)

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
por: Panebianco, Federica, et al.
Publicado: (2019)

Molecular features of aggressive thyroid cancer
por: Elia, Giusy, et al.
Publicado: (2022)

THYROID CARCINOMA-ASSOCIATED GENETIC MUTATIONS ALSO OCCUR IN THYROID LYMPHOMAS
por: Aggarwal, Nidhi, et al.
Publicado: (2012)

Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-Pandemic
por: Gorphe, Philippe, et al.
Publicado: (2021)

Is an aggressive approach justified in the management of an aggressive cancer-the squamous cell carcinoma of thyroid?
por: Chintamani, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6jsllt16p8f34acfm4g5150a0j